Publications

Aster Insights and ORIEN® have published hundreds of papers in dozens of scientific journals.

15+

Years of Data & Insights

100+

Publications

400,000

TCC® Patients

18

ORIEN® Members

Filters

Research Focus

Cancer Type

Data Utilized

ORDER BY

All Publications

    Metabolic Dysregulation Explains the Diverse Impacts of Obesity in Males and Females with Gastrointestinal Cancers. Spencer R. Rosario, Bowen Dong, et al.

    2023

    Exploiting Convergent Phenotypes to Derive a Pan-cancer Cisplatin Response Gene Expression Signature. Scarborough JA, Eschrich SA, et al.

    2023

    A bioinformatics tool for identifying intratumoral microbes from the ORIEN dataset. Cankun Wang, Anjun Ma, et al.

    2023

    The tumor microbiome as a predictor of outcomes in patients with metastatic melanoma treated with immune checkpoint inhibitors. Caroline E. Wheeler, Samuel S. Coleman IV, et al.

    2023

    Pan-cancer Landscape of Programmed Death Ligand-1 and Programmed Death Ligand-2 Structural Variations. Hoskins EL, Samorodnitsky E, et al.

    2023

    Replicative Instability Drives Cancer Progression. Morris BB, Smith JP, Zhang Q, et al.

    2022

    Factors Predicting Participation in the Prospective Genomic Sequencing Study, Total Cancer Care (TCC), in Kentucky. Riggs MJ, Huang B, Chen Q, et al.

    2022

    Systematic evaluation of the predictive gene expression signatures of immune checkpoint inhibitors in metastatic melanoma. Coleman S, Xie M, Tarhini AA, et al.

    2022

    Racial and ethnic differences in clonal hematopoiesis, tumor markers, and outcomes of patients with multiple myeloma. Peres LC, Colin-Leitzinger CM, Teng M, et al.

    2022

    Therapeutic Targeting of Protein Disulfide Isomerase PDIA1 in Multiple Myeloma. Hasipek M, Grabowski D, Guan Y, et al.

    2021

    Whitepapers

    Chart A Samples line graph, Chart B table data, Chart C Samples bar graph CRC white paperConsensus Molecular Subtype Analyses in Colorectal Cancer Samples

    April 2023
    Authors: David M. McKean, PhD, Daniel Elgort, PhD, Oliver A. Hampton, PhD, MS, Phaedra Agius, PhD

    Read Whitepaper

    Figure 2 3 charts within RCC White Paper chart OS by Risk Group, StagesIndependent confirmation of the prognostic significance of an immune-related signature in clear cell renal cell carcinoma utilizing real world clinicogenomic data

    April 2023
    Authors: Michael Radmacher, PhD, Daniel Elgort, PhD, Oliver A. Hampton, PhD, MS, and Phaedra Agius, PhD

    Read Whitepaper